A detailed history of Core First Bank & Trust transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Core First Bank & Trust holds 2,400 shares of EW stock, worth $162,624. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,400
Previous 2,400 -0.0%
Holding current value
$162,624
Previous $229,000 3.49%
% of portfolio
0.15%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 18, 2023

SELL
$69.28 - $93.38 $37,411 - $50,425
-540 Reduced 18.37%
2,400 $166,000
Q2 2023

Aug 07, 2023

SELL
$81.41 - $94.33 $43,961 - $50,938
-540 Reduced 15.52%
2,940 $277,000
Q4 2022

Feb 15, 2023

BUY
$68.3 - $87.44 $73,764 - $94,435
1,080 Added 45.0%
3,480 $259,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $172,056 - $218,952
2,400 New
2,400 $219,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.